What are peptides?
Peptides are short chains of amino acids that act as signaling molecules in the body — and they've quietly become one of the most discussed categories in modern medicine. Here's a complete primer on what peptides are, how they differ from proteins, how they work, and why they matter in 2026.
The word "peptide" has gone from biochemistry textbook to TikTok in under a decade. Drugs like Ozempic and Mounjaro made the category visible at scale. Skincare brands have built billion- dollar lines around copper peptides and signal peptides. Athletes, biohackers, and longevity researchers each have their own favorite peptides — and most of them have wildly different mechanisms even though they share a name.
That ambiguity is part of what makes the subject confusing. A peptide is technically just a short chain of amino acids — but that simple definition spans hormones, neurotransmitters, antimicrobial agents, and signaling molecules involved in nearly every biological process you can name. Saying "I'm interested in peptides" is a bit like saying "I'm interested in molecules."
This guide is the foundational primer. We'll start with what a peptide actually is, walk through how peptides differ from the things they're often confused with (proteins, amino acids, hormones), and then move into how they work, the main types, how they're made, how they're given, and the safety and regulatory landscape around them. By the end you should have a mental map for the entire category.
What is a peptide, exactly?
A peptide is a short chain of amino acids linked together by chemical connections called peptide bonds (sometimes also called amide bonds). The "short" part is what distinguishes a peptide from a protein.
The most common scientific convention is:
- Dipeptide — 2 amino acids
- Tripeptide — 3 amino acids (GHK-Cu, the copper peptide used in skincare, is a tripeptide)
- Oligopeptide — generally fewer than ~20 amino acids
- Polypeptide — typically 20 to 50 amino acids
- Protein — generally 50 amino acids or more, with complex three-dimensional folding
The boundary between long peptide and small protein is fuzzy — insulin (51 amino acids in two chains) is sometimes called a peptide hormone and sometimes a small protein. What matters more than the exact size is the function: peptides are usually signaling or binding molecules with relatively simple structure, while proteins are usually larger machines with complex folding that determines their function (enzymes, antibodies, structural proteins like collagen).
Peptides vs. proteins vs. amino acids
The cleanest way to think about it is as a hierarchy of building-block sizes.
Amino acids are the smallest unit. There are twenty standard amino acids (plus a few non-standard ones), each with a unique side chain that gives it specific chemical properties — some are hydrophobic, some are charged, some are aromatic. Your body assembles amino acids in different sequences to build everything from peptides to proteins.
Peptides are short, linear chains. They tend to have well-defined sequences but limited folding. Most peptides either circulate as messengers (binding to receptors elsewhere in the body) or are processed from precursor proteins to regulate specific pathways. Insulin, oxytocin, GLP-1, endorphins, antimicrobial peptides like LL-37 — all peptides.
Proteins are larger and more architecturally complex. They fold into specific three-dimensional shapes (secondary structure like alpha helices, tertiary structure like globular folds, sometimes quaternary structure where multiple chains assemble together). The folded shape is what gives a protein its function — antibodies fit specific antigens, enzymes fit specific substrates.
One useful intuition: proteins do most of the structural and enzymatic work in your body, while peptides do most of the signaling and regulatory work. Both are essential, but they play different roles.
How peptides work in the body
Most peptides function as signaling molecules. They are released by one tissue, travel through the bloodstream or local environment, and bind to receptors on target cells — triggering a cascade of intracellular signals that change cell behavior.
The receptors peptides bind to are typically one of two main types:
- G protein-coupled receptors (GPCRs) — the most common peptide receptor type. When a peptide binds, the receptor activates intracellular G proteins, which trigger second-messenger cascades like cAMP. Most hormonal peptides (GLP-1, oxytocin, ACTH) work through GPCRs.
- Receptor tyrosine kinases (RTKs) — used by growth-related peptides like insulin and IGF-1. When the peptide binds, the receptor's intracellular tail phosphorylates target proteins, activating pathways like PI3K/Akt that drive metabolism, growth, and survival signals.
The reason peptides are therapeutically attractive is specificity. A peptide is shaped to fit one or a small number of receptors. That means it produces narrow, targeted effects rather than the broad off-target activity that often comes with small-molecule drugs. The downside is that peptides are generally fragile (easily broken down by digestive enzymes) and have to be delivered carefully — which is why most therapeutic peptides are injected rather than taken orally.
The main types of peptides
Peptides can be grouped many ways — by structure, by source, by function. The most useful grouping for someone trying to make sense of the category is functional.
Hormonal peptides
The largest functional group. These travel through the bloodstream to regulate processes like metabolism, growth, and appetite.
- GLP-1 family — Semaglutide, Tirzepatide, Retatrutide. The class behind the modern weight-loss boom.
- Growth hormone-related peptides — CJC-1295, Ipamorelin, Sermorelin, Tesamorelin.
- Reproductive hormone regulators — Kisspeptin-10, Oxytocin.
Neuropeptides
Peptides that act as neurotransmitters or modulate brain signaling. Endorphins, oxytocin (which has a dual hormonal / neuropeptide role), and synthetic compounds like Semax and Selank fall into this category.
Antimicrobial peptides
Peptides that disrupt bacterial, viral, or fungal membranes. LL-37, defensins, and other cathelicidins are part of the body's innate immune system. Synthetic antimicrobial peptides are a growing research area for antibiotic-resistant infections.
Signal and structural peptides
Peptides that signal collagen production, wound repair, or inflammation control. Matrixyl 3000 in skincare, BPC-157 in injury research, and TB-500 for systemic recovery all fit here.
Bioactive food peptides
Peptides released during digestion of dietary protein that may have additional biological effects beyond providing amino acids. Examples include certain milk-derived peptides and the bioactive fragments produced when collagen is hydrolyzed.
Therapeutic peptides — what they treat
The therapeutic peptide market has grown dramatically. There are now roughly 80 peptide drugs approved globally across major regulatory agencies, and many more in clinical trials.
The categories where peptides have made the biggest clinical impact:
- Diabetes and weight management — GLP-1s and related compounds. Covered in detail in our weight-loss peptides guide and our top 5 weight-loss peptides post.
- Bone density — teriparatide (a parathyroid hormone fragment) for severe osteoporosis.
- Cancer — peptide-based therapeutics including GnRH analogs (leuprolide) for hormone-sensitive cancers, and an emerging field of peptide vaccines.
- Cardiovascular disease — natriuretic peptide analogs and other peptide therapeutics for heart failure.
- Chronic infections — Thymosin Alpha-1 for chronic hepatitis. Also research interest in antimicrobial peptides like LL-37.
- Tissue repair and recovery — primarily research-stage. BPC-157 and TB-500 are the most popular but not approved.
- Skin and aesthetics — copper peptides like GHK-Cu, signal peptides like Matrixyl, and neuropeptides like Argireline appear in serums and creams. Covered in our best peptide serums guide.
How peptides are made
Peptides exist in your body because cells make them — through two main mechanisms. Therapeutic peptides have a similar duality.
How the body makes peptides
Most peptides in the body are produced through one of two paths. The first is direct ribosomal synthesis: cells read messenger RNA and assemble amino acids into the peptide directly. The second is post-translational cleavage: the body makes a longer precursor protein, then enzymes cut it into smaller active peptides. Insulin is a classic example — it's cut from a larger precursor called proinsulin.
How synthetic peptides are made
Therapeutic peptides are made through one of two industrial methods.
- Solid-phase peptide synthesis (SPPS) — the standard method developed by Bruce Merrifield (Nobel Prize, 1984). Amino acids are added one at a time to a peptide chain anchored to a solid resin, washing away byproducts at each step. SPPS is the workhorse for most synthetic peptides today.
- Recombinant production — for larger peptides, engineered bacteria or yeast are programmed to produce the target peptide, which is then purified. Insulin is famously made this way using genetically modified E. coli.
The quality of peptide manufacturing is critical and varies considerably across the industry. Pharmaceutical-grade peptides go through rigorous purity, sterility, and identity testing. Research-grade peptides sold through online vendors can vary substantially in quality — which is one of the biggest concerns about gray-market peptide use.
How peptides are administered
The biggest practical limitation of peptide therapy is delivery. Peptides are biological molecules — and your digestive system is designed to break them down for nutrition before they ever reach the bloodstream.
The main routes:
- Subcutaneous injection — by far the most common. Most therapeutic peptides (semaglutide, tirzepatide, CJC-1295, BPC-157) are administered this way, usually with a small insulin syringe.
- Intramuscular injection — used for some recovery and growth-related peptides, particularly when faster absorption or higher local concentration is desired.
- Oral — historically very limited because of digestion. Recent advances in formulation chemistry have produced oral GLP-1s like Wegovy oral and the investigational Orforglipron, but these often require special permeation enhancers or non-peptide design.
- Intranasal — used for some neuropeptides (Selank, Semax, oxytocin) where direct delivery to the brain via the olfactory pathway is desirable.
- Topical — used in skincare. Copper peptides and signal peptides in serums and creams. Penetration through the skin barrier is generally limited, but enough peptide reaches the dermis to produce visible effects over time.
For dosing math on injectable peptides, our dosage calculator and reconstitution calculator run the conversions between vial size, bacteriostatic water volume, and insulin syringe units.
Safety and the regulatory landscape
Peptide safety varies enormously by compound. Peptides like semaglutide and tirzepatide have been studied in tens of thousands of patients across phase 3 trials. Peptides like BPC-157 and TB-500 have decades of animal data and broad anecdotal use but very limited large-scale human research. Newer compounds like FOXO4-DRI have only preclinical and early human data.
The regulatory landscape reflects this gradient.
- FDA-approved peptide drugs are tightly regulated, manufactured under GMP standards, and prescribed by licensed clinicians. This includes semaglutide, tirzepatide, tesamorelin, oxytocin (in clinical contexts), Thymosin Alpha-1 (approved in many countries), and others.
- Compounded peptides exist in a middle ground. Substances on the FDA's 503A bulk list can be compounded by licensed pharmacies for individual prescriptions. Most popular research peptides (BPC-157, GHK-Cu injectables, the GHRP family) are not currently on this list, but a July 2026 FDA Pharmacy Compounding Advisory Committee meeting may change that. We covered the policy landscape in our RFK peptide push piece.
- Research peptides are sold for laboratory research only. Quality varies dramatically across vendors, and human use sits in a legal and safety gray zone.
For anyone exploring peptides, the practical advice is the same as in any therapeutic decision: distinguish FDA-approved from research from gray-market sources, work with a qualified clinician, and read primary literature rather than influencer threads.
Our directory maintains profiles for every peptide discussed on this site — including mechanism, dosing references, and known side-effect profiles. Browse the full directory, or jump to specific categories like Weight Loss, Healing, Muscle Growth, or Aesthetic.
Peptides are one of the most exciting categories in modern medicine — but "exciting" cuts both ways. Used carefully, with good evidence and qualified oversight, they can produce outcomes that older drug classes couldn't approach. Used carelessly, they're a category where marketing has consistently outrun the data. The difference between those two outcomes is almost always the user's willingness to invest the time to actually understand what they're taking.
Examples of well-known peptides
Semaglutide
Appetite regulation and metabolic control
BPC-157
Tissue repair and gut lining support
GHK-Cu (Copper Peptide)
Skin regeneration, hair growth, and longevity
Ipamorelin
Selective GH release with minimal side effects
Oxytocin
Social bonding and mood
LL-37
Antimicrobial and immune modulation